Daily Headlinez Top News Updates
NEW DELHI: Several domestic companies including Sun Pharma, Torrent, Zydus, Dr Reddy’s, Glenmark and Alkem announced the launch of semaglutide on Day 1, substantially lowering the cost of weight-loss therapy.This is in the wake of the innovator Novo Nordisk losing its patent on semaglutide on March 20.Sun Pharma’s weekly therapy costs, from initiation to the…
NEW DELHI : Weight-loss therapy costs are set to reduce substantially by up to 90%, with generic versions of injectable semaglutide are expected to hit pharmacy shelves from March 21. The move kicks off one of the most closely watched price wars in the high-stakes obesity and diabetes drug market.This is in the wake of…
NEW DELHI: Once relegated to the fringes of lifestyle care, obesity drugs have emerged as one of the world’s most powerful growth sectors, ranked by McKinsey alongside AI, EVs and robotics as trillion-dollar opportunities by 2040. In India, the surge in the weight-loss and metabolic therapy market is set to shape pharma’s growth narrative in…
NEW DELHI: Weight-loss therapy drug Eli Lilly’s Mounjaro has become the top selling brand in the domestic pharma retail market with sales of nearly Rs 100 crore in Oct, indicating the huge popularity of such treatments across India. Mounjaro has overtaken GSK’s widely prescribed antibiotic and long-established market leader, Augmentin, which totalled sales of Rs…
Eli Lilly and Cipla announced an agreement to distribute and promote tirzepatide in India under a second brand name, Yurpeak. This strategic agreement aims to expand the availability of tirzepatide by enabling broader access across the country beyond cities where Lilly already has an established presence. In March, Lilly launched its blockbuster weight-loss therapy, tirzepatide…
